China tells chipmakers to use homegrown chipmaking tools for 50% of new capacity — decree designed to squeeze foreign suppliers out of supply chain

Chinese authorities have been informally instructing chipmakers seeking approvals for new or expanded fabs to spend at least 50% of equipment budgets on domestically produced tools, with waivers for advanced nodes where local options are unavailable. State-linked buyers logged 421 orders for domestic lithography machines and parts this year worth ¥850 million (~$121.3 million), a sum that equates to only a small number of low-end KrF/dry ArF steppers compared with ASML’s multi‑dozen unit production and much higher per-unit prices (KrF ~$14.5M, ArF dry ~$27.9M, immersion ArF ~$82.5M). The policy could accelerate local tool adoption and squeeze foreign suppliers in mature-node production, but current domestic gaps—especially in advanced lithography—plus case-by-case exemptions limit near-term disruption to advanced-node supply chains.

Analysis

Market structure: The informal 50% domestic-equipment quota mechanically benefits Chinese tooling firms (e.g., SMEE/688981.SS and local optics/subsystems suppliers) and state-backed mature-node fabs while pressuring foreign vendors (ASML, LRCX, AMAT) for new Chinese capex. Expect a reallocation of mature-node tool spend toward local suppliers over 12–36 months; a conservative estimate is a mid-teens reduction in addressable Chinese revenue for foreign vendors if enforcement tightens, but advanced-node exemptions cap near-term losses.

Risk assessment: Tail risks include a formal hardline law banning selected foreign tools or reciprocal Western export controls, which would cause a >20% shock to foreign-equipment revenues into China and spike volatility in 3–12 months. Hidden dependencies (foreign optics, lasers, materials) mean domestic substitution will be slow — realistic mass-replacement timelines are 24–60 months; catalysts to watch are publication of formal rules, waiver counts, and quarterly Chinese bookings for litho/etch tools.

Trade implications: Establish concentrated asymmetric positions: play domestic upside (selective longs in Chinese toolmakers) and hedge foreign exposure with time-limited options — e.g., buy 6–12 month ASML puts (10% OTM) sized to cover 1–2% portfolio risk; consider pair trade long SMEE vs short LRCX for 12–18 months. FX risk: add 0.5–1% USD/CNH long exposure for potential RMB weakness if capital flight accelerates.

Contrarian angles: The market overestimates near-term domestic capacity — Chinese-produced lithos are low-value and low-volume today, so foreign incumbents’ advanced-node pricing power (EUV/ArF immersion) stays intact; a 6–18 month sell-off would offer tactical buy-the-dip opportunities in ASML. Unintended consequence: capacity slowdowns if fabs delay builds due to tool shortages, which could support semiconductor prices and equipment order pacing globally.

Key Decisions for Investors

• Establish a 2–3% long position in Shanghai Micro Electronics (SMEE, 688981.SS) or comparable Chinese lithography/subsystem suppliers with a 12–18 month horizon; target +30–50% upside on accelerated domestic procurement, trim on +30% gains.
• Hedge or reduce direct exposure to ASML (ASML) with a tactical 1–2% notional buy of 6–9 month 10% OTM put options (or a put spread to limit cost); increase hedge to 3% if a formal written quota appears in official regulation.
• Implement a pair trade: 1.5% long SMEE (688981.SS) vs 1% short Lam Research (LRCX) or Applied Materials (AMAT) over 12 months to capture share shift in mature-node spending while limiting market beta.
• Allocate 0.5–1% of NAV to USD/CNH long positions (spot or 3–6 month forwards) as a hedge against potential RMB depreciation tied to capital outflows or policy tightening announcements within the next 3–6 months.